Exp Neurol, 2014 · DOI: 10.1016/j.expneurol.2014.06.020 · Published: November 1, 2014
This study aimed to verify if Taxol, a drug that stabilizes microtubules, could reduce scar tissue formation and improve recovery after spinal cord injury in rats. The researchers found that Taxol did reduce scarring in spinal cord injury models, specifically after dorsal hemisection (DHx) injury. However, Taxol did not improve the growth of nerve fibers or enhance functional recovery in rats with moderate spinal contusion injury.
More basic and preclinical mechanistic studies are needed before moving forward with translation of this anti-cancer drug for repair after SCI.
Taxol may be useful in reducing specific types of scarring after spinal cord injury, potentially creating a more permissive environment for axon regeneration.
Combining Taxol with other therapies that promote axon growth and neuronal survival might be necessary to achieve functional improvements after SCI.